Global Submission Strategy
Development of coherent, multi‑region regulatory strategies aligned with MHRA, EMA, FDA and ICH expectations.
Support includes planning for IND/CTA initiation, clinical progression, and MAA/NDA/BLA pathways, ensuring harmonised documentation across regions.
Agency Interaction
Strategic preparation for Scientific Advice, Type B/C meetings and other regulatory engagements.
Includes development of Briefing Books, meeting packages and clear communication strategies to facilitate productive dialogue with authorities.
Regulatory Intelligence
Continuous monitoring of evolving guidance, policy updates and global regulatory trends to proactively inform development plans and mitigate emerging risks.
Submission Authoring
Expert preparation, authoring and critical review of regulatory dossiers to ensure clarity, consistency and compliance
Support for CTIS applications, dossier compilation and submission‑ready documentation.
Post‑Approval Support
Lifecycle management of authorised products, including variations, renewals, labelling updates, and regulatory maintenance activities to ensure ongoing compliance.